Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Association between recipient TNF rs361525 and acute GVHD: results from analysis of BMT CTN-0201 samples

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Fig. 1

References

  1. Holtan SG, Pasquini M, Weisdorf DJ. Acute graft-versus-host disease: a bench-to-bedside update. Blood. 2014;124:363–73.

    Article  CAS  Google Scholar 

  2. Rashidi A, DiPersio JF, Sandmaier BM, Colditz GA, Weisdorf DJ. Steroids versus steroids plus additional agent in frontline treatment of acute graft-versus-host disease: a systematic review and meta-analysis of randomized trials. Biol Blood Marrow Transpl. 2016;22:1133–7.

    Article  CAS  Google Scholar 

  3. Rashidi A, Weisdorf D. Association between single nucleotide polymorphisms of tumor necrosis factor gene and grade II–IV acute GvHD: a systematic review and meta-analysis. Bone Marrow Transpl. 2017;52:1423–7.

    Article  CAS  Google Scholar 

  4. Simpson PD, Moysi E, Wicks K, Sudan K, Rowland-Jones SL, McMichael AJ, et al. Functional differences exist between TNFα promoters encoding the common -237G SNP and the rarer HLA-B*5701-linked A variant. PLoS ONE. 2012;7:e40100.

    Article  CAS  Google Scholar 

  5. Facon T, Jouet JP, Noel-Walter MP, Bloget F, Bauters F, Janin A. Involvement of TNF-alpha secreting macrophages in lethal forms of human graft-versus-host disease. Bone Marrow Transpl. 1997;20:511–5.

    Article  CAS  Google Scholar 

  6. Nestel FP, Price KS, Seemayer TA, Lapp WS. Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease. J Exp Med. 1992;175:405–13.

    Article  CAS  Google Scholar 

  7. Holler E, Kolb HJ, Möller A, Kempeni J, Liesenfeld S, Pechumer H, et al. Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. Blood. 1990;75:1011–6.

    CAS  PubMed  Google Scholar 

  8. Hill GR, Ferrara JL. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood. 2000;95:2754–9.

    CAS  PubMed  Google Scholar 

  9. Socié G, Mary J-Y, Lemann M, Daneshpouy M, Guardiola P, Meignin V, et al. Prognostic value of apoptotic cells and infiltrating neutrophils in graft-versus-host disease of the gastrointestinal tract in humans: TNF and Fas expression. Blood. 2004;103:50–7.

    Article  Google Scholar 

  10. Anasetti C, Logan BR, Lee SJ, Waller EK, Weisdorf DJ, Wingard JR, et al. Peripheral-blood stem cells versus bone marrow from unrelated donors. N Engl J Med. 2012;367:1487–96.

    Article  CAS  Google Scholar 

  11. Karaesmen E, Rizvi AA, Preus LM, McCarthy PL, Pasquini MC, Onel K, et al. Replication and validation of genetic polymorphisms associated with survival after allogeneic blood or marrow transplant. Blood. 2017;130:1585–96.

    Article  CAS  Google Scholar 

  12. Chien JW, Zhang XC, Fan W, Wang H, Zhao LP, Martin PJ, et al. Evaluation of published single nucleotide polymorphisms associated with acute GVHD. Blood. 2012;119:5311–9.

    Article  CAS  Google Scholar 

  13. Attia J, Ioannidis JPA, Thakkinstian A, McEvoy M, Scott RJ, Minelli C, et al. How to use an article about genetic association. JAMA. 2009;301:191.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Support for the original trial was provided to the Blood and Marrow Transplant Clinical Trials Network by grant #U10HL069294 from the National Heart, Lung, and Blood Institute and the National Cancer Institute. The Department of the Navy, Office of Naval Research, and the National Marrow Donor Program also supported this study. Enrollment support was provided by DKMS Germany. Any views, opinions, findings, conclusions or recommendations expressed in this material are those of the author(s) and do not reflect the views or the official policy or position of the above mentioned parties.

Funding

This study was funded by a University of Minnesota Marrow on the Move Award to Armin Rashidi, and in part by NIH P30 CA77598 utilizing the Biospecimen Repository in the Translational Therapy Laboratory Shared Resource of the Masonic Cancer Center, University of Minnesota.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Armin Rashidi.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Rashidi, A., Shanley, R., Yohe, S.L. et al. Association between recipient TNF rs361525 and acute GVHD: results from analysis of BMT CTN-0201 samples. Bone Marrow Transplant 53, 1069–1071 (2018). https://doi.org/10.1038/s41409-018-0127-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41409-018-0127-3

This article is cited by

Search

Quick links